{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T13:31:08Z","timestamp":1759411868150},"reference-count":9,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biologicals"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.biologicals.2018.07.005","type":"journal-article","created":{"date-parts":[[2018,8,31]],"date-time":"2018-08-31T02:19:50Z","timestamp":1535681990000},"page":"9-12","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["A risk assessment on extraneous virus contamination in a viral vaccine production environment justifies waiving of in vivo testing"],"prefix":"10.1016","volume":"56","author":[{"given":"Uffe B.","family":"Westergaard","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bodil","family":"van Overeem Hansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kasper Abildgaard","family":"Rud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claus","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gitte","family":"Stawski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaare R.","family":"Hasl\u00f8v","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"24","key":"10.1016\/j.biologicals.2018.07.005_bib1","doi-asserted-by":"crossref","first-page":"2916","DOI":"10.1016\/j.vaccine.2014.02.021","article-title":"Systematic evaluation of in vitro and in vivo adventitious virus assays for the detection of viral contamination of cell banks and biological products","volume":"32","author":"Gombold","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2018.07.005_bib2","unstructured":"DIRECTIVE 2010\/63\/EU of THE EUROPEAN PARLIAMENT and of the COUNCIL of 22 September 2010 on the protection of animals used for scientific purposes."},{"key":"10.1016\/j.biologicals.2018.07.005_bib3","unstructured":"Ph.Eur. 5.2.14 (01\/2018): Substitution of in vivo methods by in vitro methods for quality control of vaccines."},{"key":"10.1016\/j.biologicals.2018.07.005_bib4","series-title":"Validation of analytical procedures: text and methodology","author":"International Conference on harmonization","year":"2005"},{"key":"10.1016\/j.biologicals.2018.07.005_bib5","series-title":"FMEA from theory to execution","author":"Failure Mode and Effect Analysis","year":"2003"},{"key":"10.1016\/j.biologicals.2018.07.005_bib6","series-title":"Textbook of medical virology","year":"1983"},{"issue":"2","key":"10.1016\/j.biologicals.2018.07.005_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.jviromet.2013.06.038","article-title":"A novel enterovirus and parechovirus multiplex one-step real-time PCR-validation and clinical experience","volume":"193","author":"Nielsen","year":"2013","journal-title":"J Virol Methods"},{"key":"10.1016\/j.biologicals.2018.07.005_bib8","unstructured":"Ph.Eur 2.6.16 (01\/2018): Tests for extraneous agents in viral vaccines for human use."},{"key":"10.1016\/j.biologicals.2018.07.005_bib9","unstructured":"Ph.Eur 5.2.3 (01\/2018): Cell substrates for the production of vaccines for human use."}],"container-title":["Biologicals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1045105618302422?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1045105618302422?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,12]],"date-time":"2018-11-12T18:36:27Z","timestamp":1542047787000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1045105618302422"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":9,"alternative-id":["S1045105618302422"],"URL":"https:\/\/doi.org\/10.1016\/j.biologicals.2018.07.005","relation":{},"ISSN":["1045-1056"],"issn-type":[{"value":"1045-1056","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A risk assessment on extraneous virus contamination in a viral vaccine production environment justifies waiving of in vivo testing","name":"articletitle","label":"Article Title"},{"value":"Biologicals","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biologicals.2018.07.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 International Alliance for Biological Standardization. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}